Valuation: Incyte Corporation

Market Cap 2.35TCr 2.06TCr 1.92TCr 1.76TCr 3.31TCr 2,26400Cr 3.36TCr 23TCr 8.91TCr 1,11300Cr 8.83TCr 8.63TCr 3,84800Cr P/E 2026 *
57x
P/E 2027 * 15.3x
Enterprise Value 1.95TCr 1.71TCr 1.59TCr 1.46TCr 2.75TCr 1,87800Cr 2.79TCr 19TCr 7.39TCr 92TCr 7.32TCr 7.16TCr 3,19200Cr EV / Sales 2026 *
3.39x
EV / Sales 2027 * 2.83x
Free-Float
98.11%
Yield 2026 *
-
Yield 2027 * -
1 day+0.84%
1 week+0.36%
Current month+3.80%
1 month+8.49%
3 months+24.32%
6 months+15.37%
Current year+19.14%
1 week 114.5
Extreme 114.505
119.13
1 month 109.48
Extreme 109.475
119.6
Current year 89.25
Extreme 89.25
119.6
1 year 69.7
Extreme 69.695
119.6
3 years 50.27
Extreme 50.27
119.6
5 years 50.27
Extreme 50.27
119.6
10 years 50.27
Extreme 50.27
153.15
Manager TitleAgeSince
Chief Executive Officer 58 26/06/2025
Director of Finance/CFO 57 04/05/2026
President 62 05/06/2023
Director TitleAgeSince
Chairman 59 26/06/2025
Director/Board Member 72 20/01/2015
Director/Board Member 64 20/01/2015
Date Insider Type Main position Quantity % Market Cap.
16/07/26 Free

EVP, Human Resources

39,018 0.0195%
16/07/26 Free

Principal Accounting Officer

6,913 0.0035%
16/07/26 Sell

Chief Technology Officer

-78,469 0.0393%
Change 5-day change 1-year change 3-year change Capi.($)
+0.84%+0.36%+66.93%+85.42% 2.35TCr
+0.63%-3.06%+16.18%-9.78% 6.67TCr
+1.23%+2.80%+37.51%+202.14% 5.33TCr
+10.08%+51.80%+51.80%+51.80% 4.81TCr
-1.32%-7.38%-57.63%-57.10% 3.83TCr
+0.78%-1.84%+52.49%-27.01% 2.99TCr
-5.17%-12.54%+58.98%-56.04% 2.15TCr
-1.21%+1.12%+1.98%+170.93% 2TCr
-0.22%-0.95%+61.97%+123.78% 1.64TCr
+1.31%+3.24%+84.01%+152.77% 1.65TCr
Average +1.29%-0.57%+37.42%+63.69% 3.34TCr
Weighted average by Cap. +1.78%+0.06%+30.57%+55.05%

Financials

2026 *2027 *
Net sales 574.84Cr 504.88Cr 469.53Cr 430.85Cr 809.54Cr 55TCr 822.02Cr 5.58TCr 2.18TCr 27TCr 2.16TCr 2.11TCr 94TCr 620.51Cr 545Cr 506.83Cr 465.09Cr 873.86Cr 60TCr 887.33Cr 6.02TCr 2.35TCr 29TCr 2.33TCr 2.28TCr 1,01600Cr
Net income 43Cr 37Cr 35Cr 32Cr 60Cr 4.11TCr 61Cr 413.59Cr 161.58Cr 2.02TCr 160.07Cr 156.62Cr 6.98TCr 159.17Cr 139.8Cr 130.01Cr 119.3Cr 224.15Cr 15TCr 227.61Cr 1.54TCr 603.15Cr 7.54TCr 597.51Cr 584.64Cr 26TCr
Net Debt -400.7Cr -351.93Cr -327.29Cr -300.33Cr -564.3Cr -39TCr -573Cr -3.89TCr -1.52TCr -19TCr -1.5TCr -1.47TCr -66TCr -592.68Cr -520.55Cr -484.1Cr -444.23Cr -834.67Cr -57TCr -847.54Cr -5.75TCr -2.25TCr -28TCr -2.22TCr -2.18TCr -97TCr
Logo Incyte Corporation
Incyte Corporation specializes in the research & development of therapeutic products mainly intended for the treatment of cancers and inflammatory disorders. Net sales break down by revenue source as follows: - product sales (84.7%); - royalties (12.4%); - income from research and cooperation agreements (2.9%).
Employees
2,844
Date Price Change Volume
24/26/24 $117.67 +0.84% 12,07,106
23/26/23 $116.69 +0.78% 9,56,259
22/26/22 $115.79 -1.36% 9,98,480
21/26/21 $117.39 +1.50% 19,06,845
20/26/20 $115.65 -1.36% 12,57,145
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
117.67USD
Average target price
114.55USD
Spread / Average Target
-2.66%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. INCY Stock